.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A06A_DrugsForConstipation.A06AX08_Tenapanor.Tenapanor

Information

name:Tenapanor
ATC code:A06AX08
route:oral
n-compartments1

Tenapanor is an inhibitor of the sodium/hydrogen exchanger 3 (NHE3) located in the intestines, approved for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) and, in some regions, for hyperphosphatemia in chronic kidney disease patients on dialysis.

Pharmacokinetics

Healthy adults, both sexes, evaluated after oral administration; tenapanor has minimal systemic absorption, thus systemic exposure is negligible.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos